ArisGlobal announces CHEPLAPHARM selected LifeSphere platforms for pharmacovigilance
CHEPLAPHARM will use MultiVigilance, Business Intelligence, and Medical Information to support global safety operations and growth.
See the latest news and media coverage for ArisGlobal. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences software and artificial intelligence company
arisglobal.comLast updated
In short: ArisGlobal was acquired by Dassault Systèmes for $1.8 billion and launched several AI-driven life sciences automation platforms.
CHEPLAPHARM will use MultiVigilance, Business Intelligence, and Medical Information to support global safety operations and growth.
The acquisition will create a unified AI intelligence platform connecting molecule, patient, and real-world outcomes.
Regulatory affairs must take responsibility for product data to avoid inconsistencies that hinder AI and compliance with IDMP standards
New AI capabilities reduce manual data entry by up to 80% and accelerate triage by 70%.
Check out today's featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT...
Dassault Systèmes will acquire ArisGlobal for $1.8 billion, plus a variable component linked to revenue generated by AI.
Additional consideration up to $200 million linked to AI revenues (Il Sole 24 Ore Radiocor) - Rome, Aug 4 - Dassault Systemes announces that...
French software maker Dassault Systèmes confirmed its full-year outlook on Thursday after reporting second-quarter revenue ...
Track ArisGlobal and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to ArisGlobal and other trending companies.